Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Hot topic

The future of HPAPIs according to industry insiders

29-Nov-2011 - High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.

China-focused USP committee to develop excipient standards

29-Nov-2011 - USP is creating a China-focused East Asia expert committee to develop quality standards for excipients.

Drug delivery research round-up

28-Nov-2011 - in-PharmaTechnologist presents its round-up of the latest drug delivery research developments in the pharmaceutical world, including tumour targeting peptides and lipid nanoparticle drug-delivery technology.

FDA anti-adulteration efforts hindered by industry; GAO

28-Nov-2011 - Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.

GSK urges FDA to consider absorption of nanomaterials in new guidance

23-Nov-2011 - GlaxoSmithKline (GSK) has urged the US FDA consider the absorption of nanomaterials in the gastrointestinal (GI) tract within its proposal for new regulations on nanotechnology.

FDA nanomaterial draft guidance means pointless extra regulation, say experts

22-Nov-2011 - FDA draft guidance defines nanoparticles too broadly and could result in APIs being categorised as nanomaterials, industry said.

Gold nanoparticles can cut blood supply to tumours, say researchers

21-Nov-2011 - Gold nanoparticles can target endothelial cells to cut the supply of oxygen to most types of tumour, according to a new study.

Ashland predicts ISP buy will accelerate pharma unit growth

17-Nov-2011 - Ashland expects integration of ISP and demand for pharma ingredients to drive “accelerated growth” in the next few years.

Aanjaneya’s profit soars as post-IPO expansion continues

17-Nov-2011 - Net profit at Indian API and formulation business Aanjaneya Lifecare jumped as it enacted post-IPO expansion plans to ‘dominate’ its markets.

India to end ‘anti-competitive’ bulk drug price control policy

17-Nov-2011 - India plans to end price control of bulk drugs as the practice ‘is inherently anti-competitive’ and gives China an advantage.

Endeavour creates new intermediates for prion drug developers

16-Nov-2011 - Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments.

Pharma must improve existing methods to boost solubility as “quantum leap” unlikely

15-Nov-2011 - To boost solubility pharma must develop, refine and improve existing methods as a “quantum leap” in formulation is unlikely, Pharmaterials' CEO said.

Bristol-Myers Squibb inks tech transfer with Brazilian MoH for HIV meds

14-Nov-2011 - Bristol-Myers Squibb has penned a technology transfer agreement with the Brazilian government in what it says is a bid to increase access to HIV drug Reyataz (atazanavir sulfate) in the area.

News in brief

EDQM has busy month of CEP suspensions

14-Nov-2011 - The EDQM has suspended five CEPs in a little over a month, bringing the total to nine so far this year.

Bosch packaging to open second production plant in China

09-Nov-2011 - Bosch Packaging has started work on a second production facility in Chengdu, China to increase manufacturing capacity.

K-V prompts FDA investigation into compounding pharmacies

09-Nov-2011 - The FDA is investigating compounding pharmacies’ Makena after K-V Pharmaceutical said they differ from approved forms.

Globalised supply chain drives EMA to rethink batch release

09-Nov-2011 - The EMA plans to update guidance on certification and batch release in response to globalisation of the pharma supply chain.

BASF to enter synthetic menthol market in 2012

08-Nov-2011 - BASF will start producing synthetic menthol next year using a new method that, it claims, offers significant quality and supply advantages for drug and food manufacturers.

update

Novozymes rolls out new HA product

03-Nov-2011 - Novozymes Biopharma says its new hyaluronic acid has sustainability, safety and production benefits for the pharmaceutical manufacturing sector.

ViiV teams with Russian manufacturer

03-Nov-2011 - ViiV, GSK and Pfizer’s HIV joint venture, has partnered with Russia’s JSC Binnopharm to boost manufacturing capacity in the country.

Chiral surfaces could cut manufacturing costs, say researchers

02-Nov-2011 - Using chiral metal surfaces in drug manufacturing could save companies time and money, say researchers at University of Cambridge.

Round-up of news & views from AAPS & CPhI 2011

31-Oct-2011 - In-PharmaTechnologist presents a roundup of news and views shared by exhibitors and attendees at AAPS and CPhI.

Delivery vehicles can revitalise RNAi sector; AAPS panel

31-Oct-2011 - Aptamers and dendrimers can revitalise the faltering siRNA sector by solving delivery problems, AAPS panelists said.

Excipient auditor certification scheme ready for 2012 launch, says IPEC

24-Oct-2011 - Industry groups developing certification standards for third-party auditors of pharmaceutical excipient manufacturers say they are ready to launch the scheme next year.

Merck plans $250m Singapore manufacturing expansion

24-Oct-2011 - Merck & Co is investing $250m (€180m) in its Singapore manufacturing capabilities as part of an expansion push.

Sign up for your free newsletter